The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Anderson Thomas since 2014.
This trader's CIK number is 1612903.
At the time of last reporting, Anderson Thomas was the Director of Zevra Therapeutics, Inc.. (stock ticker symbol ZVRA).
Also see all insider trading activities at Zevra Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | SAGE | 0 | $0 | 10,000 | $550,000 | 11,900 | $106,148 |
| 2015 | SAGE | 0 | $0 | 11,500 | $836,179 | 5,500 | $49,060 |
| 2014 | SAGE | 6,000 | $108,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ZVRA | 10,000 | $68,070 | 0 | $0 | 0 | $0 |
| 2023 | ZVRA | 10,000 | $48,760 | 0 | $0 | 0 | $0 |
1. Sage Therapeutics, Inc. (SAGE)
2. Zevra Therapeutics, Inc. (ZVRA)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-12-15 | SAGE | Option Ex | 1,900 | 8.92 | 16,948 |
| 2016-11-15 | SAGE | Sale | 10,000 | 55.00 | 550,000 |
| 2016-11-15 | SAGE | Option Ex | 10,000 | 8.92 | 89,200 |
| 2015-08-10 | SAGE | Sale | 6,000 | 66.71 | 400,277 |
| 2015-06-08 | SAGE | Sale | 5,500 | 79.25 | 435,902 |
| 2015-06-08 | SAGE | Option Ex | 5,500 | 8.92 | 49,060 |
| 2014-07-23 | SAGE | Buy | 6,000 | 18.00 | 108,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-07-16 | ZVRA | Buy | 10,000 | 6.81 | 68,070 |
| 2023-09-06 | ZVRA | Buy | 10,000 | 4.88 | 48,760 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Anderson Thomas (Director of Zevra Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.